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Abstract
Discrete choice experiments (DCEs) are economic tools that elicit the stated preferences of respondents. Because of their 
increasing importance in informing the design of health products and services, it is critical to understand the extent to which 
DCEs give reliable predictions outside of the experimental context. We systematically reviewed the literature of published 
DCE studies comparing predictions to choices made in reality; we extracted individual-level data to estimate a bivariate 
mixed-effects model of pooled sensitivity and specificity. Eight studies met the inclusion criteria, and six of these gave suf-
ficient data for inclusion in a meta-analysis. Pooled sensitivity and specificity estimates were 88% (95% CI 81, 92%) and 34% 
(95% CI 23, 46%), respectively, and the area under the SROC curve (AUC) was 0.60 (95% CI 0.55, 0.64). Results indicate 
that DCEs can produce reasonable predictions of health-related behaviors. There is a great need for future research on the 
external validity of DCEs, particularly empirical studies assessing predicted and revealed preferences of a representative 
sample of participants.
Keywords Discrete choice experiment · External validity · Hypothetical bias · Meta-analysis
JEL Classification C590 · I100 · C830
Introduction
Discrete choice experiments (DCEs) ask participants to 
make choices between hypothetical alternatives, using 
choice modeling methods to analyze data. They are attractive 
tools for research and policy as they offer a flexible method-
ology to estimate which attributes are important in decision-
making. Participants are asked to choose their preferred of, 
generally, between two and five alternatives over a number 
of choice tasks (usually around ten). Data are analyzed using 
discrete choice models [1], the results of which can be used 
to determine the relative importance of different attributes 
to respondent choices. Results can also be used to predict 
demand, termed market shares in the marketing literature 
[2]. DCEs are being increasingly used in health to study 
patient and/or physician preferences in academic studies, 
health technology assessments, and regulatory risk–benefit 
assessment [3, 4]. Particularly useful is the ability to include 
products or attributes in DCEs which do not exist in reality, 
and for which no observational or trial data exist [5].
In recent years, DCEs have proven increasingly popular 
in the health domain, whilst a large (mostly non-health) eco-
nomic literature has developed around the design, analysis, 
and application of DCEs [2, 6, 7]. Yet DCEs ask respondents 
to make hypothetical choices, and it is important to ensure 
that they measure what researchers think that they do. Dis-
parities between revealed and stated preference data are, in 
part, due to the hypothetical nature of DCE tasks; this diver-
gence is termed hypothetical bias. There has been no widely 
accepted theory to explain hypothetical bias which, follow-
ing Beck et al. [8], we define in this paper as discrepancies 
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between preferences exhibited in DCEs to those exhibited in 
reality. Hypothetical bias may originate when choice tasks 
do not fully reflect reality in the nature or characteristics of 
choices, when respondents have incomplete preferences, or 
if respondents perceive a vested interest in over- or under-
stating the importance of particular attributes.
Where the true attributes of a good or service are known, 
predicted probability analysis (PPA) uses DCE results to 
predict utility-maximizing choices. Under the assumption 
that individuals are rational, DCEs can approximate which 
choice people would make given the option in reality [9, 
10]. PPA is common outside of health and is increasingly 
being applied by health economists to predict demand for a 
range of health-related choices, including HIV prevention 
products [11], contraceptive services [12], vaccination [13], 
and migraine treatments [9].
In the early stages of introducing health products or 
services, there is often a great deal of uncertainty around 
their potential impact and subsequent cost-effectiveness. 
DCE predictions can be particularly useful for estimating 
the uptake of new products or services where observational 
data, from trials or pilot projects, are not available [12, 13]. 
In the absence of observational data, for example in from a 
pragmatic trial or demonstration project, “expert opinion” 
is often used to generate uptake predictions, which are then 
commonly used to inform impact or cost-effectiveness mod-
els [14]. In a previous paper, the authors of this study sug-
gest that DCEs can provide a useful empirical alternative to 
expert opinion, whist also offering additional benefit through 
accounting for synergistic relationships between different 
product and service attributes and use, which are commonly 
ignored [15].
Background on validity in DCEs
In health, around 60% of studies include internal theoretical 
validity checks, whilst non-satiation and transitivity tests are 
applied less frequently [3]. A recent study demonstrated that, 
of the 112 health DCEs published in 2015, 49% included at 
least one internal validity check, yet there were substantial 
differences in how researchers dealt with indications of poor 
validity, i.e., 46% of studies using a dominance test excluded 
respondents who failed the test [16].
By contrast, external validity is concerned with ensur-
ing the comparability of hypothetical and actual choices. 
Because respondents are not obliged in reality to make the 
choices they indicate in a DCE, hypothetical bias may reduce 
the usefulness of DCE results [17, 18]. There have been 
some substantive contributions to the methodological lit-
erature on the external validity of DCEs (e.g., [19–22]), yet 
much of the focus in the literature has been on maximiz-
ing the internal validity of DCEs. Whilst this is important, 
there has been very little empirical work assessing whether 
choices made in DCEs in fact reflect those made in reality, 
or the circumstances in which they may offer more or less 
reliable inference [19].
This paper considers variations in external validity in health 
DCEs attributable to hypothetical bias, and is the first system-
atic review and meta-analysis assessing the ability of DCEs to 
predict health behaviors. Proving external validity is impor-
tant to the practical application and use of DCEs, yet despite 
their growing popularity, there has been little research on their 
external validity in the health domain [21, 22].
There are many reasons why hypothetical bias may exist, 
including that people may be fundamentally rational but 
inconsistent in utility maximization, e.g., when they are pay-
ing more or less attention to a decision context. Indeed, the 
choice architecture surrounding real-world and hypothetical 
choices has been shown to affect choices, including healthy 
eating, physical activity, and alcohol use [23–25]. Further-
more, if DCEs are not incentive compatible, respondents may 
try and answer strategically, for example to understate their 
willingness to pay for public services [26, 27]. Behavioral eco-
nomic research challenges the theory that we are all variants of 
homo economicus, but there has been limited work exploring 
if behavioral heuristics influence preferences to a greater or 
lesser extent in stated preference tasks than in reality [28, 29]. 
Additional reasons why differences may exist in health fields 
include: difficulties in acquiring revealed preference data due 
to failures in healthcare markets; the lack of a market analogue 
for many health decisions; or vested interests from researchers 
not wanting to reveal the ability (or lack thereof) of DCE mod-
els to accurately predict choices and behavior [20, 22, 30, 31].
We note that literature exists, mostly outside of a health 
context, evaluating the external validity of WTP estimates 
from stated preference exercises. These exercises are dif-
ferent from DCEs whereby, instead of participants choos-
ing between a set of alternatives, people are presented with 
open-ended questions, for example how much they would 
be willing to pay to avoid a certain occurrence. The exter-
nal validity of WTP estimates has been explored fully and 
recently in the literature, and we therefore do not include 
WTP studies in this review. This work explores the exter-
nal validity of willingness-to-pay estimates from contingent 
valuations and conjoint analyses, mostly in transport fields 
[32–34], including three meta-analyses [35–37]. These stud-
ies conclude that hypothetical bias can be substantial, with 
median bias levels ranging from 25 to 300%. Furthermore, 
efforts to reduce hypothetical bias through a number of 
methods, such as increasing consequentiality of choices or 
“cheap-talk” strategies, have also been shown to have mixed 
results [25, 38–40].
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Rationale for review and aim
There has been no synthesis of the predictive abilities of 
DCEs in health, despite a substantive and recent increase in 
the number of studies using estimated choice probabilities 
from DCEs to predict choices, e.g., [9, 41]. These studies 
implicitly assume that DCEs have sufficient external valid-
ity to provide meaningful results. More generally, there has 
been no systematic review of studies exploring the external 
validity of any stated preference tasks in health. Existing 
reviews focus on summarizing DCE applications [3, 7, 42], 
collating preference research on particular health or disease 
areas [43, 44], or synthesizing methodological innovations 
to maximize internal validity [45].
This review aims to systematically review studies com-
paring stated preference choices, as modeled through 
predicted probability models resultant from DCE data, to 
revealed preference choices as gathered through obser-
vational or survey means. We report published evidence, 
describe the quality of included studies using an adapted 
quality checklist, and quantitatively synthesize the predictive 
ability of DCEs.
This review is the first to systematically evaluate and 
synthesize studies which observe participants’ stated and 
revealed preferences through comparing DCE data to real-
life health choices. Its findings will enable researchers and 
policymakers to assess how useful DCEs might be in pre-
dicting individual choices.
Methods
Search strategy
We searched the following databases to ensure a compre-
hensive exploration of the health, economic, and decision 
science literature: (1) PubMed/Medline; (2) EMBASE; (3) 
CINAHL; (4) Econlit; (5) Social Policy and Practice; (6) 
Science Direct. An iterative strategy was employed and the 
references of identified articles examined by hand for further 
relevant material. The search included all available years up 
to August 2015. The following keywords (alongside relevant 
MeSH terms where databases permitted) were used to build 
the search strategy:
• Discrete choice experiments (“discrete choice* OR 
choice experiment* OR stated preference* OR DCE OR 
conjoint analysis”)
  AND
• External validity (“external validity OR predict* OR 
hypothetical bias* OR market share* OR revealed pref-
erence*”)
Inclusion and exclusion criteria
We included studies using a discrete choice experiment 
methodology to predict health-related choices and compared 
these predictions with observed choices in real life. Studies 
were not excluded by population or the nature of choice tasks 
presented to participants. Studies obtaining revealed prefer-
ence data from lab-based studies were excluded as these 
may be subject to similar concerns over external validity as 
DCEs themselves. The term conjoint analysis was explic-
itly included in the search strategy, and studies incorrectly 
labeled as conjoint analyses, when they were in fact DCEs, 
were included in the screening process. We excluded:
1. Studies using a preference elicitation method other than 
a discrete choice experiment (for example, contingent 
valuation or conjoint analyses);
2. Studies using “lab-based” experiments to elicit revealed 
preferences;
3. Letters, general commentaries or perspectives;
4. Studies without English language titles or abstracts.
Screening of studies for eligibility
We imported all identified references into reference man-
agement software [46] and removed duplicates. First, titles 
and abstracts were screened by one researcher and irrelevant 
articles excluded. Secondly, the full text of selected papers 
was screened independently by two researchers against the 
eligibility criteria. Any disagreements were resolved by dis-
cussion. Records of studies were kept as per the Preferred 
Reporting Items for Systematic Reviews and Meta-Analysis 
(PRISMA) checklist [47]. Data were then extracted into a 
predefined extraction form. Where information was lack-
ing, attempts were made to contact corresponding authors 
to obtain the maximum quantity of data.
Assessment of study quality
The characteristics of included studies were assessed by two 
reviewers against a tool of 17 criteria based on that of Man-
deville et al. [42], which is itself an adaptation of the “good-
practice” checklist of Lancsar and Louviere [48]. The quality 
criteria tool used is presented in supplementary material S1. 
We remove the criteria of using an efficient design, since 
this may not be an indicator of study quality, and the criteria 
of ensuring a sufficient response rate due to the subjectiv-
ity of what may be considered sufficient. In addition, we 
amend the criteria that attribute and level choice should be 
“grounded in qualitative work with the target population”, 
to “grounded in piloting work with the target population”. 
Mandeville et al.’s method only assesses criteria which may 
substantively affect the quality of included studies, thereby 
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avoiding common criticisms of quality checklists that they 
are poorly correlated with study validity and measure the 
quality of reporting rather than that of the underlying study 
[49].
The checklist of Lancsar and Louviere does not consider 
external validity, except through the broad question “Was 
internal or external validity investigated?”. Therefore, we 
drop this criterion in favor of five further criteria to assess 
the reliability of external validity assessment. We based four 
of these criteria on Lancsar and Swait [50] who specify some 
testable reasons that stated preference models might fail to 
be externally valid. Finally, we note the potential for selec-
tion bias in studies where observational data were gathered 
on a non-random subset of DCE participants and include an 
additional criterion to ensure that we account for potential 
selection bias in comparisons between predicted and actual 
choices. Both reviewers independently evaluated the quality 
of included studies by assessing whether the criterion for 
each study was met or not. If the information available for 
a criterion was insufficient to evaluate its achievement, we 
noted this as a separate category.
Statistical analysis
Because DCE predictions are a form of binary classifica-
tion test, to synthesize the outcomes of included studies, 
we employ the array of methods used in assessing clinical 
diagnostic tests. In the context of DCE predictions, high 
sensitivity (true-positive rate) would indicate reliability 
in predicting opting-in behaviors. We define an opting-in 
behavior as a choice, in the DCE or a real-world context, to 
use a product or service that a respondent does not currently 
use. High specificity (true-negative rate) would indicate reli-
ability in predicting opting-out behaviors, which we define 
as a respondent choosing not to use a product or service in 
the DCE or real-world context.
Synthesizing sensitivity and specificity estimates requires 
more sophistication than other quantitative syntheses, due 
to between-study heterogeneity, and the correlation between 
sensitivity and specificity estimates. When differences 
between studies are thought to be only due to sampling 
variation, it would be appropriate to pool estimates though 
sample size-weighted averages of sensitivity and speci-
ficity. However, it is likely that variability beyond chance 
can be attributed to between-study differences (e.g., study 
design, method of data collection, context, interviewer, or 
self-administration). Due to the range of DCE methods and 
study contexts, we use a random effects model to attempt 
to account for explainable and unexplainable heterogeneity 
[51].
There is likely to be interdependence between sensitivity 
and specificity measures, which requires specific considera-
tion in meta-analytic models [52]. To account for this, we 
use bivariate mixed-effects logistic regression through the 
midas command in STATA 14, which assumes independ-
ent binomial distributions for true positives and negatives 
conditional on the sensitivity and specificity in each study 
[53, 54]. By jointly modeling sensitivity and specificity, this 
method preserves the bivariate data structure of the data 
and is an improvement on the standard analysis method of 
applying the DerSimonian and Laird random effects model 
[51]. The potential for publication bias was assessed through 
Egger’s test [55]. No test for publication bias is without 
methodological issue [56], yet Egger’s test for funnel plot 
asymmetry is recommended for use by PRISMA guidelines 
[57].
Finally, we conduct bivariate multivariable meta-regres-
sion to explore heterogeneity by regressing sensitivity and 
specificity estimates on five study-level characteristics: 
mode of DCE administration (paper/computer), whether the 
DCE is related to a prevention or treatment choice, the num-
ber of DCE choice sets, the number of alternatives within 
a choice set, and the percentage of DCE respondents for 
whom revealed preference data were analyzed. The effect 
of each covariate on sensitivity and specificity is estimated 
separately [53].
Results
Figure 1 details the flow of papers through the study. In total, 
6383 studies were identified through database searching and 
one additional study identified through its presentation at 
a health economics conference. The full text of 13 articles 
was reviewed for eligibility, eight were considered for a 
qualitative synthesis, and six included sufficient quantita-
tive information for inclusion in a meta-analysis. Figure 2 
shows publications identified by year.
Notably, there were very few studies which directly 
assessed the external validity of DCE predictions. Of the 
studies that have been published (two were found in pre-
publication, conference abstract stage, one of which was 
published whilst this study was under review [58]), five 
(63%) were published since 2015, suggesting that the exter-
nal validity of DCEs is receiving more attention than in the 
past. Seven studies (88%) sought to predict the choices of 
patients over a broad range of health choices, from vaccina-
tion to sexually transmitted infection testing, to prospective 
mother’s choice of birth location. One study sought to pre-
dict the choices of healthcare professionals as they appraised 
new medicines. Six studies (75%) presented information at 
the individual level and are included in the meta-analysis.
How well do discrete choice experiments predict health choices? A systematic review and…
1 3
Assessment of quality of included studies
Results from the quality assessment of included studies are 
presented in supplementary material S2. Overall, the quality 
of studies was high; the design and implementation of DCEs 
were often of good quality. However, the additional criteria 
we add to explore the robustness of study external validity 
indicate some notable weaknesses.
When assessed by criteria outside of those exploring 
external validity, the included studies were of high quality. 
For example, most DCEs were piloted in a relevant target 
population and allowed participants to “opt-out” of making 
Fig. 1  PRISMA diagram of 
review process
0
1
2
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4
5
2009 2010 2011 2012 2013 2014 2015 2016
Included Studies by Year
Fig. 2  Summary of publication date of included studies
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a choice. However, included studies may be subject to selec-
tion bias. The response rate of the DCE task was often low, 
while data on actual behavior was not gathered for the full 
sample of people who completed the DCE. If participants 
who did not complete the DCE, or who did and were not 
followed-up, are non-randomly different from those who 
were included in final analyses, systematic bias would be 
introduced into results. If participants were more likely to 
be included in follow-up when they opted-into a choice, this 
would overstate the predictive ability of DCEs.
We note that two studies meeting the inclusion criteria, 
Mohammadi et al. [59] and Chua et al. [60], were identi-
fied in conference abstract form. Although the former was 
published as a full paper during the review process of this 
study [58], the latter was not, and does not include sufficient 
information to assess against all quality criteria.
Quantitative synthesis
Table 1 presents information on all included studies, while 
Table 2 displays the data extracted to assess the predictive 
ability of DCEs. We consider 844 observations where opt-in 
or opt-out choices were correctly predicted 75% of the time; 
65% of incorrect predictions were false-positives. Figure 3 
displays the sensitivity and specificity estimates for each 
study.1 These estimates were calculated from the raw data.
In this context, DCEs predict that an individual will either 
make or not make a particular choice in reality. Therefore, 
a higher sensitivity would indicate that DCEs are good at 
predicting when individuals would choose reality, while a 
higher specificity would indicate that DCEs reliably predict 
that individuals will not make a particular choice.
We use a bivariate random-effects model to account for 
substantive heterogeneity between studies, and produce 
pooled estimates of sensitivity and specificity. Pooled esti-
mation suggests that the sensitivity of DCE predictions was 
relatively high (0.88, 95% CI 0.81, 0.92), whilst specificity 
was substantially lower (0.34, 95% CI 0.23, 0.46). These 
results suggest that DCEs can be moderately informative for 
predicting future behavior. Specifically, when DCE data sug-
gest that somebody will behave in a certain way (for exam-
ple, opting for a treatment or programme), this is a more 
reliable statement than when DCEs suggest somebody will 
not behave in a certain way (for example, they will not use 
a treatment or programme). There is no consistent pattern 
of the number of false positives outweighing the number of 
false negatives, however it is possible that imperfect sensi-
tivity may result in DCEs over-predicting demand. For the 
remainder of this paper, we will use the term “opt-in” to 
denote those participants who the DCE predicts would use 
a product or service.
As sensitivity and specificity estimates are pooled 
through bivariate random-effects modeling, we expect the 
two estimates to be interdependent. Supplementary material 
S3 shows a bivariate box plot which describes the extent to 
which sensitivity and specificity are interdependent with the 
inner oval representing the median distribution of estimates, 
and the outer oval the 95% confidence bound. These results 
indicate that there was a degree of heterogeneity between 
included studies, as three reside outside of the median dis-
tribution while one study tends towards being defined an 
outlier. There was no strong indication of a skew towards 
sensitivity or specificity. According to Egger’s test, there 
was no evidence of publication bias (p = 0.56), however the 
capacity for this test to detect publication bias from a limited 
number of small studies is limited [55].
Visual examination of results, shown in Fig. 3, suggests 
that there was substantial between-study variation. The 
quantity I2 statistic describes the percentage of total varia-
tion across studies, which can be attributed to heterogeneity 
rather than due to chance, where an I2 of 0% indicates that 
there was no heterogeneity between studies while an I2 of 
above 50% suggests substantial heterogeneity [53, 61]. The 
I2 estimates for sensitivity and specificity are 64 and 58%, 
respectively, indicating that while there was substantial het-
erogeneity in both measures, estimates of sensitivity were 
subject to greater variation. Finally, we assessed publication 
bias through Egger’s test, which suggests no evidence of 
publication bias (p = 0.56). However, the capacity for this 
test to detect publication bias from a limited number of small 
studies is limited [55].
Under the presence of heterogeneity, summary receiver 
operating characteristic (SROC) curves can be used to dis-
play the results of syntheses where the higher the combined 
sensitivity and specificity of a test (i.e., the greater true-posi-
tive rate), the closer the SROC curve will be to the top left of 
the SROC space [52]. Figure 4 shows the SROC for included 
studies, where the curve represents the relationship between 
the true- and false-positive rates across studies and was fitted 
to the data through least-squares regression [62]. The area 
under the SROC curve (AUC) can be a useful summary sta-
tistic of predictive ability, and the AUC we present in Fig. 4 
(0.60 [95% CI 0.55, 0.64]) provides further evidence that 
DCEs have a moderate ability to predict choices; although 
there are no firm limits for “good” AUCs, meta-analyses of 
diagnostic tests infer a similar conclusions [63, 64].
Finally, the results of univariable meta-regression are 
presented in Fig. 5 and show that, even among the small 
number of studies, the specificity of DCE predictions is sig-
nificantly and positively associated with the SP/RP response 
rate, alongside the number of alternatives shown in choice 
tasks. No factor is significantly associated with greater or 
1 One study (Krucien et  al.) predicts the uptake of two treatments, 
and we present each separately in this analysis.
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lower sensitivity. These results will become more precise 
and allow greater influence as more studies are published 
assessing the predictive ability of DCEs.
Discussion
This paper reports the results of a systematic literature 
review and meta-analysis and proposes a method to 
strengthen predictions made from DCE data. The sys-
tematic review identified seven studies as meeting the 
inclusion criteria. The meta-analysis of six studies with 
individual-level data found that DCEs have moderate, but 
not exceptional, accuracy when predicting health-related 
choices. Pooled sensitivity and specificity estimates were 
88% (95% CI 81, 92%) and 34% (95% CI 23, 46%), respec-
tively. All DCEs included in this review were exploring 
opting-in behaviors, and the mean observed uptake of 
options across all studies in this review was high at 76% 
(638 out of 844 observations). Only one study reported 
a measure of uncertainty around uptake predictions. The 
sensitivity of predictions was found to be greater than their 
specificity, suggesting that DCEs are better at predicting 
who would opt-into a health-related decision rather than 
who would not. Overall, the review found very few studies 
comparing DCE predictions to observed choices at an indi-
vidual level, and this is a key priority for future research.
We explored heterogeneity through use of meta-regres-
sion by incorporating study-level characteristics into bivari-
ate mixed-effects models, and found evidence that the RP/
SP follow-up rate and the number of alternatives presented 
to respondents were positively associated with estimates of 
Fig. 3  Synthesis of sensitivity 
and specificity of DCE predic-
tions
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Fig. 4  Summary receiver-operator curve (SROC) of included studies
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specificity, but not sensitivity. This study, being the first to 
synthesize evidence on the predictive ability of DCEs, is 
the first to show the extent of the heterogeneity in speci-
ficity when predicting behaviors, and care is needed when 
interpreting the results of DCE predictions. Due to the low 
number of studies in the literature, this analysis was under-
powered and future research should focus on identifying the 
determinants of DCE external validity in order that DCEs 
and prediction methods give predictions with the greatest 
accuracy.
The finding that opt-in predictions from DCEs are reliable 
is useful for planning interventions and programmes. This 
quantification of how well DCEs predict behavior could be 
used to explicitly account for uncertainty in DCE predic-
tions, for example by using the pooled sensitivity point esti-
mate and confidence intervals from this study to give upper 
and lower bounds of opting-in behaviors. Accounting for the 
variation in DCE prediction accuracy in this manner would 
make for more robust uptake and impact models. Although 
the pooled specificity estimate suggests that DCEs are not 
good predictors of opting-out behavior (i.e., should not be 
trusted when predicting that someone will not uptake a prod-
uct or service), the pooled sensitivity estimate was relatively 
high and precise, making it suitable for this application.
Paper-based
Computer-based
Treatment-related
Prevention-related
No. choice sets
No. alternatives
RP/SP responses
0.41 0.97
Sensitivity(95% CI)
*p<0.05, **p<0.01, ***p<0.001
Paper-based
Computer-based
Treatment-related
Prevention-related
No. choice sets
*No. alternatives
*RP/SP responses
0.13 0.96
Specificity(95% CI)
*p<0.05, **p<0.01, ***p<0.001
Univariable Meta-regression & Subgroup Analyses
Fig. 5  Meta-regression results
How well do discrete choice experiments predict health choices? A systematic review and…
1 3
When considering how useful DCEs are in predicting 
behavior, we must consider the alternative data sources 
available to decision-makers. When predicting the demand 
for new health products or services, there is likely to be 
almost no information to base these forecasts on. One option 
is to run a pilot study or demonstration project; however, 
even on a small scale, these can be both expensive and time-
consuming. Another option would be to canvass expert opin-
ion; however, even experts with the best of intentions can 
be incorrect or biased in their estimates. In such instances, 
DCEs can provide a relatively accurate and cost-effective 
option to predict individual choices. DCEs have been pro-
posed for use to parameterize uptake and use parameters in 
health economic modeling [15], and if used for this purpose, 
parameter uncertainty could be partly accounted for using 
estimates from this review to adjust uptake estimates.
There may be some reasons why observed choices may be 
different to those predicted by DCEs. Firstly, the information 
presented in DCE choice tasks is necessarily a simplification 
of reality. Even in the case of high-quality DCEs, there are 
likely to be unobserved attributes present in real-life deci-
sions that were not, or poorly, accounted for in the DCE. 
Where these unobserved attributes influence the decisions 
of participants, stated and revealed preferences will be based 
on heterogeneous choice attributes and may diverge. Even 
high-quality DCEs are unlikely to fully capture all relevant 
attributes of choice.
Secondly, DCE predictions may suffer from the intention-
behavior gap where individuals do not always ultimately 
behave in ways which they might intend to [65, 66]. For 
example, when people are a long way ahead of making 
a choice, they are more likely to commit to a substantial 
course of action (such as giving up smoking), however as 
they move closer to the choice situation they are more likely 
to choose the smaller reward (have a cigarette). This hyper-
bolic discounting suggests the passage of time changes the 
perception of the situation and choices, potentially explain-
ing variation between DCE predictions and actual behavior.
Results assume that there is a generalizable and meas-
urable concept of DCE external validity. However, this 
review was limited by the small number of studies identified 
which met the inclusion criteria. This meant that we were 
unable to undertake a meaningful analysis of where DCEs 
may provide more or less accurate predictions. For exam-
ple, Ryan and Watson [67] find that a DCE for Chlamydia 
screening has a high false-negative rate (where more people 
are screened in reality than predicted in the DCE), whereas 
Mohammadi et al. [58] find a high false-positive rate of 
DCEs predicting treatment for tuberculosis (where the DCE 
over-predicted successful treatment). With a larger number 
of studies, it would have been interesting to explore whether 
such divergent results may have been down to study con-
text (treatment requires continued adherence and not just a 
one-off action), cognitive biases (perhaps social desirability 
bias to predict successful treatment or not disclose demand 
for a Chlamydia test outside of a consultation environment), 
or other reasons.
The meta-analytic tools used in this review are often 
employed to assess diagnostic tests, with the data normally 
used to assess these tests gathered in strictly controlled 
environments. In contrast, the DCEs in this study cover 
a range of health choices across a broad range of popula-
tions, and it is perhaps no surprise that there was sub-
stantial heterogeneity between studies. Finally, predicted 
probabilities are just one interpretation of DCE results. 
Although probabilities are calculated using the coefficients 
of DCE models, this review explores just one interpreta-
tion of DCE results.
When compared against existing quality assessment 
tools, the quality of the included studies was high. How-
ever, when assessed against the additional external validity 
criteria, all but two studies were substantially prone to 
selection bias. As none of these studies gave any detail 
as to how participants were selected for follow-up, we are 
unable to fully assess how reliable these estimates might 
be.
A limitation of this review is the assessment of DCE 
predictive ability, which is just one facet of external valid-
ity. Assessing the external validity of WTP estimates was 
beyond the scope of this review, whilst the external valid-
ity of WTP estimates have been robustly assessed in three 
systematic reviews and meta-analyses since 2004 [35–37]. 
In addition, included studies must have been able to define 
participants’ choice sets in the real world, implicitly lim-
iting the scope of this review to predictions of choices 
within choice sets which can be represented consistently in 
a stable manner across real-world and hypothetical tasks, 
e.g., uptake of a test, but not adherence to a treatment 
over time.
Although the sample size of included studies was incor-
porated in the standard error around pooled estimates, we 
are not able to account for potential publication or selec-
tion biases. The pooled sensitivity estimates are based 
on a multi-stage follow-up—participants must initially 
consent to participate in a DCE, then be successfully fol-
lowed up to ascertain whether or not they engaged in a pre-
dicted behavior. A recent meta-analysis indicates that the 
response rates to DCE surveys are often relatively low, and 
vary according to contextual factors such as the number of 
attributes or population surveyed [68]. This review could 
not incorporate divergent choices from those who did not 
respond to DCEs in these samples, nor those who were lost 
to follow-up. Non-responders or those lost to follow-up 
may be systematically different from the included sample. 
Finally, we did not assess the internal validity of included 
studies. Although DCEs may vary in their predictive 
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power absolute terms, the choice-modeling literature sug-
gests that their ability to give reliable data on the relative 
impact of some factors on choices is much more robust.
Conclusions
This study sought to systematically review the external 
validity of DCEs and is the first to synthesize studies assess-
ing the predictive ability of DCEs in health. Seven studies 
were identified as meeting the inclusion criteria, and a meta-
analysis of six studies with individual-level data found that 
DCEs have moderate, but not exceptional, accuracy when 
predicting health-related choices. Pooled sensitivity and 
specificity estimates were 88% (95% CI 81, 92%) and 34% 
(95% CI 23, 46%), respectively. This review and meta-analy-
sis suggests that DCEs can be useful in predicting real-world 
behavior, and provides important estimates of sensitivity and 
specificity which can be explicitly incorporated into impact 
and economic models. There is a substantial need for more 
evidence on how DCE predictions compare to real-world 
choices.
Author contributions MQ conceived the study and all authors contrib-
uted to its design. MQ screened titles, abstracts and full texts, carried 
out analysis, and wrote the first draft of the manuscript. FTP reviewed 
the abstracts and full texts. All authors read and approved the final 
manuscript.
Funding MQ receives a Ph.D. studentship from the Economic and 
Social Research Council. No funder had a role in the design, analysis 
or writing of this article.
Compliance with ethical standards 
Conflict of interest No conflicts of interest to declare.
Open Access This article is distributed under the terms of the Crea-
tive Commons Attribution 4.0 International License (http://creat iveco 
mmons .org/licen ses/by/4.0/), which permits unrestricted use, distribu-
tion, and reproduction in any medium, provided you give appropriate 
credit to the original author(s) and the source, provide a link to the 
Creative Commons license, and indicate if changes were made.
References
 1. McFadden, D.: Conditional logit analysis of qualitative choice 
behaviour. In: Zarembka, P. (ed.) Frontiers in Econometrics. Aca-
demic Press, New York (1974)
 2. Hensher, D., Rose, J., Greene, W.: Applied Choice Analysis, 2nd 
edn. Cambridge University Press, Cambridge (2015)
 3. Clark, M.D., et al.: Discrete choice experiments in health econom-
ics: a review of the literature. Pharmacoeconomics 32(9), 883–902 
(2014)
 4. Muhlbacher, A.C., et al.: Preferences for antiviral therapy of 
chronic hepatitis C: a discrete choice experiment. Eur. J. Health 
Econ. 18(2), 155–165 (2017)
 5. Louviere, J.J., Lancsar, E.: Choice experiments in health: the 
good, the bad, the ugly and toward a brighter future. Health Econ. 
Policy Law 4(Pt 4), 527–546 (2009)
 6. Ben-Akiva, M.E., Lerman, S.R.: Discrete Choice Analysis: The-
ory and Application to Travel Demand. MIT Press, Boston (1985)
 7. de Bekker-Grob, E.W., Ryan, M., Gerard, K.: Discrete choice 
experiments in health economics: a review of the literature. Health 
Econ. 21(2), 145–172 (2012)
 8. Beck, M.J., Fifer, S., Rose, J.M.: Can you ever be certain? Reduc-
ing hypothetical bias in stated choice experiments via respond-
ent reported choice certainty. Transp. Res. Part B Methodol. 89, 
149–167 (2016)
 9. Bingham, M.F., Johnson, F.R., Miller, D.: Modeling choice behav-
ior for new pharmaceutical products. Value Health 4(1), 32–44 
(2001)
 10. McFadden, D.L.: Chapter 24 econometric analysis of qualitative 
response models. In: Zvi, G., Michael, D.I. (eds.) Handbook of 
Econometrics, pp. 1395–1457. Elsevier, Amsterdam (1984)
 11. Quaife, M., et al.: The cost-effectiveness of multipurpose HIV and 
pregnancy prevention technologies in South Africa. J. Int. AIDS 
Soc. (2018). https ://doi.org/10.1002/jia2.25064 
 12. Fiebig, D.G., et al.: Preferences for new and existing contraceptive 
products. Health Econ. 20(Suppl 1), 35–52 (2011)
 13. Hall, J., et al.: Using stated preference discrete choice modelling 
to evaluate the introduction of varicella vaccination. Health Econ. 
11(5), 457–465 (2002)
 14. Terris-Prestholt, F., et al.: How much demand for New HIV pre-
vention technologies can we really expect? Results from a discrete 
choice experiment in South Africa. PLoS ONE 8(12), e83193 
(2013)
 15. Terris-Prestholt, F., Quaife, M., Vickerman, P.: Parameterising 
user uptake in economic evaluations: the role of discrete choice 
experiments. Health Econ. 25, 116–123 (2016)
 16. Schmidt-Ott, T., et al.: Rationality tests in discrete choice experi-
ments—the pros and cons of testing dominant alternatives. In: 
7th Meeting of the International Academy of Health Preference 
Research. Glasgow, UK (2017)
 17. Mitchell, R.C., Carson, R.T.: Using Surveys to Value Public 
Goods: The Contingent Valuation Method. Hopkins University 
Press, Baltimore (1989)
 18. Cummings, R.G., Brookshire, S., Schulze, W.D.: Valuing Envi-
ronmental Goods: A State of the Arts Assessment of the Contin-
gent Valuation Method, Volume I.B of Experimental Methods 
for Assessing Environmental Benefits. Rowman and Allanheld, 
Totowa (1986)
 19. Lancsar, E., Swait, J.: Reconceptualising the external validity of 
discrete choice experiments. Pharmacoeconomics 32, 951–965 
(2014)
 20. Hensher, D.A.: Hypothetical bias, choice experiments and willing-
ness to pay. Transp. Res. Part B Methodol. 44(6):735–752 (2010)
 21. Ryan, M., Gerard, K.: Using discrete choice experiments to value 
health care programmes: current practice and future research 
reflections. Appl Health Econ Health Policy 2(1), 55–64 (2003)
 22. Telser, H., Zweifel, P.: Validity of discrete-choice experiments evi-
dence for health risk reduction. Appl. Econ. 39(1), 69–78 (2007)
 23. Hollands, G.J., et al.: Altering micro-environments to change 
population health behaviour: towards an evidence base for choice 
architecture interventions. BMC Public Health 13(1), 1218 (2013)
 24. Barrage, L., Lee, M.S.: A penny for your thoughts: inducing truth-
telling in stated preference elicitation. Econ. Lett. 106(2):140–142 
(2010)
 25. Bosworth, R., Taylor, L.O.: Hypothetical bias in choice experi-
ments: is cheap talk effective at eliminating bias on the intensive 
How well do discrete choice experiments predict health choices? A systematic review and…
1 3
and extensive margins of choice? BE J. Econ. Anal. Policy 12(1) 
(2012)
 26. Lusk, J.L., Schroeder, T.C.: Are choice experiments incentive 
compatible? A test with quality differentiated beef steaks. Am. J. 
Agric. Econ. 86(2), 467–482 (2004)
 27. McCartney, A., Cleland, J.: Choice experiment framing and 
incentive compatibility: observations from public focus groups. 
Environmental Economics Research Hub Research Reports from 
Environmental Economics Research Hub, Crawford School of 
Public Policy, The Australian National University (2010)
 28. Neuman, E.: Reference-dependent preferences for maternity 
wards: an exploration of two reference points. Health Psychol. 
Behav. Med. 2(1), 440–447 (2014)
 29. Howard, K., Salkeld, G.: Does attribute framing in discrete choice 
experiments influence willingness to pay? Results from a discrete 
choice experiment in screening for colorectal cancer. Value Health 
12(2), 354–363 (2009)
 30. Lancsar, E., Swait, J.: Reconceptualising the external valid-
ity of discrete choice experiments. 32(10):951–965 (2014). 
http://rd.sprin ger.com/journ al/40273 . http://ovids p.ovid.
com/ovidw eb.cgi?T=JS&PAGE=refer ence&D=emed1 
2&NEWS=N&AN=20156 39269 
 31. Vossler, C.A., Watson, S.B.: Understanding the consequences of 
consequentiality: testing the validity of stated preferences in the 
field. J. Econ. Behav. Organ. 86, 137–147 (2013)
 32. Brownstone, D., Small, K.A.: Valuing time and reliability: assess-
ing the evidence from road pricing demonstrations. Transp. Res. 
Part A Policy Pract. 39(4), 279–293 (2005)
 33. Isacsson, G.: The trade off between time and money: is there a 
difference between real and hypothetical choices? Tinbergen Insti-
tute Discussion Papers 13-123/VIII, Tinbergen Institute (2007) 
(revised 25 Aug 2013)
 34. Loomis, J.: What’s to know about hypothetical bias in stated pref-
erence valuation studies? J. Econ. Surveys 25(2):363–370 (2011)
 35. Murphy, J.J., et al.: A meta-analysis of hypothetical bias in stated 
preference valuation. Environ. Resour. Econ. 30(3):313–325 
(2005)
 36. List, J., Gallet, C.: What experimental protocol influence dis-
parities between actual and hypothetical stated values? Environ. 
Resour. Econ. 20(3), 241–254 (2001)
 37. Little, J., Berrens, R.: Explaining disparities between actual and 
hypothetical stated values: further investigation using meta-anal-
ysis. Econ. Bull. 3(6), 1–13 (2004)
 38. Alpizar, F., Carlsson, F., Johansson-Stenman, O.: Does context 
matter more for hypothetical than for actual contributions? Evi-
dence from a natural field experiment. Exp. Econ. 11, 299–314 
(2008)
 39. Silva, A., et al.: Can perceived task complexity influence cheap 
talk’s effectiveness in reducing hypothetical bias in stated choice 
studies? App. Econ. Lett. 19(17):1711–1714 (2012)
 40. Ready, R.C., Champ, P.A., Lawton, J.L.: Using respondent uncer-
tainty to mitigate hypothetical bias in a stated choice experiment. 
Land Econ. 86(2):363–381 (2010)
 41. Viney, R., Lancsar, E., Louviere, J.: Discrete choice experiments 
to measure consumer preferences for health and healthcare. Expert 
Rev. Pharmacoecon. Outcomes Res. 2(4), 319–326 (2002)
 42. Mandeville, K.L., Lagarde, M., Hanson, K.: The use of discrete 
choice experiments to inform health workforce policy: a system-
atic review. BMC Health Serv. Res. 14, 367 (2014)
 43. Purnell, T.S., et al.: Patient preferences for noninsulin diabetes 
medications: a systematic review. Diabetes Care 37(7), 2055–2062 
(2014)
 44. Lewis, R.A., et al.: Patients’ and healthcare professionals’ views 
of cancer follow-up: systematic review. Br. J. Gen. Pract. 59(564), 
e248–e259 (2009)
 45. Harrison, M., et al.: Risk as an attribute in discrete choice experi-
ments: a systematic review of the literature. Patient Patient Cent. 
Outcomes Res. 7(2), 151–170 (2014)
 46. Thompson Reuters, EndNote X7. (2013)
 47. Moher, D., et  al.: Preferred Reporting Items for Systematic 
Reviews and Meta-Analyses: the PRISMA statement. PLoS Med. 
6(7), e1000097 (2009)
 48. Lancsar, E., Louviere, J.: Conducting discrete choice experiments 
to inform healthcare decision making: a user’s guide. Pharmaco-
economics 26(8), 661–677 (2008)
 49. Juni, P., et al.: The hazards of scoring the quality of clinical trials 
for meta-analysis. JAMA 282(11), 1054–1060 (1999)
 50. Lancsar, E., Swait, J.: Reconceptualising the external validity of 
discrete choice experiments. Pharmacoeconomics 32(10), 951–
965 (2014)
 51. Hamza, T.H., van Houwelingen, H.C., Stijnen, T.: The binomial 
distribution of meta-analysis was preferred to model within-study 
variability. J. Clin. Epidemiol. 61(1), 41–51 (2008)
 52. Harbord, R.M., et al.: A unification of models for meta-analysis 
of diagnostic accuracy studies. Biostatistics 8(2), 239–251 (2007)
 53. Dwamena, B.: MIDAS: STATA module for meta-analytical inte-
gration of diagnostic test accuracy studies. https ://econp apers 
.repec .org/RePEc :boc:bocod e:s4568 80 (2009). Accessed 18 Dec 
2017
 54. StataCorp, STATA 14. (2014)
 55. Egger, M., et al.: Bias in meta-analysis detected by a simple, 
graphical test. BMJ 315(7109), 629–634 (1997)
 56. Bland, M.: Meta-analysis: heterogenity and publication bias. 
http://wwwus ers.york.ac.uk/~mb55/msc/systr ev/week7 /hetpu 
b-compa ct.pdf (2006). Accessed 18 Dec 2017
 57. Liberati, A., et al.: The PRISMA statement for reporting system-
atic reviews and meta-analyses of studies that evaluate health 
care interventions: explanation and elaboration. PLoS Med. 6(7), 
e1000100 (2009)
 58. Mohammadi, T., et al.: Testing the external validity of a discrete 
choice experiment method: an application to latent tuberculosis 
infection treatment. Value Health 20(7), 969–975 (2017)
 59. Mohammadi, T.: Exploring the external validity of discrete choice 
experiment using hierarchical Bayes mixed logit: an application to 
latent tuberculosis. In: International Health Economics Associa-
tion Congress. Milan, Italy (2015)
 60. Chua, G.N., et al.: External validity of discrete choice experi-
ments: findings from a field experiment. In: Health Economists’ 
Study Group (HESG) Meeting. University of Manchester, Man-
chester, UK (2016)
 61. Higgins, J.P., et al.: Measuring inconsistency in meta-analyses. 
BMJ 327(7414), 557–560 (2003)
 62. Walter, S.D.: Properties of the summary receiver operating char-
acteristic (SROC) curve for diagnostic test data. Stat. Med. 21(9), 
1237–1256 (2002)
 63. Engels, E.A., et al.: Meta-analysis of diagnostic tests for acute 
sinusitis. J. Clin. Epidemiol. 53(8), 852–862 (2000)
 64. Lee, A., et al.: A systematic review (meta-analysis) of the accuracy 
of the Mallampati tests to predict the difficult airway. Anesth. 
Analg. 102(6), 1867–1878 (2006)
 65. Sheeran, P.: Intention—behavior relations: a conceptual and 
empirical review. Eur. Rev. Soc. Psychol. 12(1), 1–36 (2002)
 66. Ajzen, I.: The theory of planned behavior. Organ. Behav. Hum. 
Decis. Process. 50(2), 179–211 (1991)
 67. Ryan, M., Watson, V.: Comparing welfare estimates from payment 
card contingent valuation and discrete choice experiments. Health 
Econ. 18(4), 389–401 (2009)
 68. Watson, V., Becker, F., de Bekker-Grob, E.: Discrete choice 
experiment response rates: a meta-analysis. Health Econ. 26(6), 
810–817 (2016)
 M. Quaife et al.
1 3
 69. Krucien, N., Gafni, A., Pelletier-Fleury, N.: Empirical testing of 
the external validity of a discrete choice experiment to determine 
preferred treatment option: the case of sleep apnea. Health Econ. 
24(8), 951–965 (2015)
 70. Lambooij, M.S., et al.: Consistency between stated and revealed 
preferences: a discrete choice experiment and a behavioural 
experiment on vaccination behaviour compared. BMC Med. Res. 
Methodol. 15, 19 (2015)
 71. Salampessy, B.H., et al.: The predictive value of discrete choice 
experiments in public health: an exploratory application. Patient 
8(6), 521–529 (2015)
 72. Kruk, M.E., et al.: Women’s preferences for place of delivery in 
rural Tanzania: a population-based discrete choice experiment. 
Am. J. Public Health 99(9), 1666–1672 (2009)
 73. Linley, W.G., Hughes, D.A.: Decision-makers’ preferences for 
approving new medicines in Wales: a discrete-choice experiment 
with assessment of external validity. Pharmacoeconomics 31(4), 
345–355 (2013)
